Literature DB >> 28296810

Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis.

Manu Shankar-Hari1, David Fear, Paul Lavender, Tracey Mare, Richard Beale, Chad Swanson, Mervyn Singer, Jo Spencer.   

Abstract

OBJECTIVE: Sepsis is life-threatening organ dysfunction due to dysregulated host responses to infection. Current knowledge of human B-cell alterations in sepsis is sparse. We tested the hypothesis that B-cell loss in sepsis involves distinct subpopulations of B cells and investigated mechanisms of B-cell depletion.
DESIGN: Prospective cohort study.
SETTING: Critical care units. PATIENTS: Adult sepsis patients without any documented immune comorbidity.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: B-cell subsets were quantified by flow cytometry; annexin-V status identified apoptotic cells and phosphorylation of intracellular kinases identified activation status of B-cell subsets. B cell-specific survival ligand concentrations were measured. Gene expression in purified B cells was measured by microarray. Differences in messenger RNA abundance between sepsis and healthy controls were compared. Lymphopenia present in 74.2% of patients on admission day was associated with lower absolute B-cell counts (median [interquartile range], 0.133 [0.093-0.277] 10 cells/L) and selective depletion of memory B cells despite normal B cell survival ligand concentrations. Greater apoptotic depletion of class-switched and IgM memory cells was associated with phosphorylation of extracellular signal-regulated kinases, implying externally driven lymphocyte stress and activation-associated cell death. This inference is supported by gene expression profiles highlighting mitochondrial dysfunction and cell death pathways, with enriched intrinsic and extrinsic pathway apoptosis genes.
CONCLUSIONS: Depletion of the memory B-cell compartment contributes to the immunosuppression induced by sepsis. Therapies targeted at reversing this immune memory depletion warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28296810     DOI: 10.1097/CCM.0000000000002380

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

Review 1.  Immunoglobulins and sepsis.

Authors:  Manu Shankar-Hari; Martin Bruun Madsen; Alexis F Turgeon
Journal:  Intensive Care Med       Date:  2018-01-18       Impact factor: 17.440

Review 2.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

3.  Cellular and molecular mechanisms of IMMunE dysfunction and Recovery from SEpsis-related critical illness in adults: An observational cohort study (IMMERSE) protocol paper.

Authors:  Matthew Fish; Kate Arkless; Aislinn Jennings; Julie Wilson; Michael J Carter; Gill Arbane; Sara Campos; Neus Novellas; Rianne Wester; Nedyalko Petrov; Umar Niazi; Barney Sanderson; Richard Ellis; Mansoor Saqi; Jo Spencer; Mervyn Singer; Rocio T Martinez-Nunez; Simon Pitchford; Chad M Swanson; Manu Shankar-Hari
Journal:  J Intensive Care Soc       Date:  2020-11-06

4.  Transcriptomic depression of immunological synapse as a signature of ventilator-associated pneumonia.

Authors:  Raquel Almansa; Leonor Nogales; Marta Martín-Fernández; Montse Batlle; Esther Villareal; Lucia Rico; Alicia Ortega; Guillermo López-Campos; David Andaluz-Ojeda; Paula Ramírez; Lorenzo Socias; Luis Tamayo; Jordi Vallés; Jesús F Bermejo-Martín; Ignacio Martín-Loeches
Journal:  Ann Transl Med       Date:  2018-11

Review 5.  Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression.

Authors:  Chao Ren; Hui Zhang; Tian-Tian Wu; Yong-Ming Yao
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

6.  Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.

Authors:  Julie K Wilson; Yuan Zhao; Mervyn Singer; Jo Spencer; Manu Shankar-Hari
Journal:  Crit Care       Date:  2018-04-17       Impact factor: 9.097

7.  A dynamic COVID-19 immune signature includes associations with poor prognosis.

Authors:  Adam G Laing; Anna Lorenc; Irene Del Molino Del Barrio; Abhishek Das; Matthew Fish; Leticia Monin; Miguel Muñoz-Ruiz; Duncan R McKenzie; Thomas S Hayday; Isaac Francos-Quijorna; Shraddha Kamdar; Magdalene Joseph; Daniel Davies; Richard Davis; Aislinn Jennings; Iva Zlatareva; Pierre Vantourout; Yin Wu; Vasiliki Sofra; Florencia Cano; Maria Greco; Efstathios Theodoridis; Joshua D Freedman; Sarah Gee; Julie Nuo En Chan; Sarah Ryan; Eva Bugallo-Blanco; Pärt Peterson; Kai Kisand; Liis Haljasmägi; Loubna Chadli; Philippe Moingeon; Lauren Martinez; Blair Merrick; Karen Bisnauthsing; Kate Brooks; Mohammad A A Ibrahim; Jeremy Mason; Federico Lopez Gomez; Kola Babalola; Sultan Abdul-Jawad; John Cason; Christine Mant; Jeffrey Seow; Carl Graham; Katie J Doores; Francesca Di Rosa; Jonathan Edgeworth; Manu Shankar-Hari; Adrian C Hayday
Journal:  Nat Med       Date:  2020-08-17       Impact factor: 87.241

8.  Relationship between Anaemia, Haemolysis, Inflammation and Haem Oxygenase-1 at Admission with Sepsis: a pilot study.

Authors:  Phebe Ekregbesi; Manu Shankar-Hari; Christian Bottomley; Eleanor M Riley; Jason P Mooney
Journal:  Sci Rep       Date:  2018-07-25       Impact factor: 4.379

9.  Increased mortality in CD43-deficient mice during sepsis.

Authors:  Katherine T Fay; Deena B Chihade; Ching-Wen Chen; Nathan J Klingensmith; John D Lyons; Kimberly Ramonell; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

10.  Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis.

Authors:  Catia Cilloniz; Héctor José Peroni; Albert Gabarrús; Carolina García-Vidal; Juan M Pericàs; Jesús Bermejo-Martin; Antoni Torres
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.